Consolidated Statements of Cash Flows - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
CASH FLOW FROM OPERATING ACTIVITIES
Net income		$ 2,369	$ 3,078	$ 4,696
Adjustments to reconcile net income to net cash from operating activities:
Discontinued operations, net		(262)	(212)	(1,364)
Depreciation, depletion and amortization of assets		7,533	6,951	6,449
Deferred income tax provision (benefit)		127	(265)	54
Other noncash charges to income		420	454	133
Asset impairments		21	355	209
Losses (gains) on sales of assets and other, net		(263)	60	(522)
Undistributed losses (earnings) from equity investments		619	(83)	141
Dry hole expense		109	106	299
Changes in operating assets and liabilities:
(Increase) decrease in trade receivables		252	(116)	931
(Increase) decrease in inventories		12	(27)	(84)
(Increase) decrease in joint interest receivables and other current assets		(62)	286	(350)
Decrease in accounts payable and accrued liabilities		(964)	(540)	(423)
Increase (decrease) in current domestic and foreign income taxes		(305)	472	66
Operating cash flow from continuing operations		9,606	10,519	10,235
Operating cash flow from discontinued operations		926	920	2,073
Net cash provided by operating activities		10,532	11,439	12,308
CASH FLOW FROM INVESTING ACTIVITIES
Capital expenditures		(6,427)	(6,263)	(5,696)
Change in capital accrual		32	100	(22)
Purchases of assets, businesses and equity investments, net		(280)	(9,117)	(713)
Proceeds from sale of assets and equity investments, net		2,278	1,673	447
Equity investments and other, net		(286)	(214)	(479)
Investing cash flow from continuing operations		(4,683)	(13,821)	(6,463)
Investing cash flow from discontinued operations		(1,116)	(769)	(517)
Net cash used by investing activities		(5,799)	(14,590)	(6,980)
CASH FLOW FROM FINANCING ACTIVITIES
Draws on receivables securitization facility		0	0	283
Payment of receivables securitization facility		0	0	(283)
Proceeds from long-term debt, net		0	9,612	(46)
Payments of long-term debt, net		(3,754)	(4,514)	(22)
Redemption of preferred stock		0	0	(1,661)
Purchases of treasury stock		0	(27)	(1,798)
Cash dividends paid on common and preferred stock		(1,594)	(1,446)	(1,365)
Proceeds from issuance of common stock		966	584	135
Contributions from noncontrolling interest		200	200	100
Deferred payments for purchases of assets and businesses		(417)	(318)	0
Other financing, net		(236)	(242)	(229)
Financing cash flow from continuing operations		(4,835)	3,849	(4,886)
Financing cash flow from discontinued operations		(9)	(5)	(4)
Net cash provided (used) by financing activities		(4,844)	3,844	(4,890)
Increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents		(111)	693	438
Cash, cash equivalents, restricted cash and restricted cash equivalents — beginning of year		2,157	1,464	1,026
Cash, cash equivalents, restricted cash and restricted cash equivalents — end of year		2,046	2,157	1,464
CASH, CASH EQUIVALENTS, RESTRICTED CASH AND RESTRICTED CASH EQUIVALENTS BALANCES FROM:
Continuing operations - beginning of year		2,150	1,451	1,006
Discontinued operations - beginning of year	[1]	7	13	20
Less: discontinued operations - end of year	[1]	41	7	13
Continuing operations - end of year		$ 2,005	$ 2,150	$ 1,451

[1] Reported as assets held for sale on our consolidated balance sheets.